Back to Results
First PageMeta Content
Food and Drug Administration / Pharmacology / Clinical research / Pharmaceutical industry / Microbicides for sexually transmitted diseases / Docetaxel / FDA Special Protocol Assessment / New Drug Application / Clinical trial / Pharmaceutical sciences / Medicine / Health


Microsoft Word - Starpharmadocx
Add to Reading List

Document Date: 2014-07-14 20:17:07

Open Document

File Size: 191,08 KB

Share Result on Facebook

City

Melbourne / /

Company

Eli Lilly / Recommendation Buy (unchanged) Risk Starpharma / Phase III BV / Symptomatic Relief VivaGel BV / VivaGel VivaGel VivaGel Dendrimer-Docetaxel Dendrimer-Glyphosate BV / Fred Truong Resources / Nufarm / Ansell Dendrimer-Docetaxel (first solid tumour) Dendrimer-Glyphosate Diagnostics / Elanco / R-BV Trials Starpharma / COMPANY DESCRIPTION Starpharma / GICS Sector Pharmaceuticals / Pharmaceuticals & Biotechnology Expected Return Capital / VivaGel BV / Astra Zeneca / Sanofi Aventis / Makhteshim Agan / Bell Potter Limited / Ge / Bell Potter Securities Limited. / Okamoto / Gowan Company / Dow Chemical Company / GSK / Fixed Income Bell Potter Securities Limited / Speculative SPA / BIND Therapeutics / Acorn Capital / Starpharma Holdings Ltd. / /

Continent

Europe / Asia / North America / /

Country

Japan / United Kingdom / United States / /

Currency

USD / AUD / /

Event

FDA Phase / Business Partnership / Bankruptcy / Analyst Recommendation / /

Facility

Absolute Price The SPA / Safety bar / Laboratory Reagents Other Pipeline/Non-allocated Cash / Terminal Growth Rate At / /

IndustryTerm

continuous use product / pipeline products / trial protocol / platform technology / biotechnology stocks / pharmaceuticals / biotechnology investments / typical biotechnology company lies / insurance product / biotechnology sector / biotechnology / dendrimer technology / industrial applications / placebo / Biotechnology developers / chronic use product / /

MarketIndex

S&P 300 / /

MedicalCondition

Viral Conjunctivitis / solid tumours / Bacterial Vaginosis / non-small cell lung cancer / prostate cancer / breast cancer / cancer / NSCLC / chronic use BV product / recurrent Bacterial Vaginosis / diseases / Sexually Transmitted Infections / chronic use product / tumours / gastric cancer / head and neck cancer / common vaginal infection / tumour / /

MedicalTreatment

dendrimer / dendrimers / /

Organization

Securities and Futures Commission / FDA / NM PER / office of Hematology and Oncology / EMA / /

Person

Barry Ziegler / Damien Williamson / Tim Piper / Tanushree Jain / Allan Gray / /

/

Position

blai Research Assistant / MANAGER IN THE OCTOBER / investment adviser / representative / MODEL AT THIS STAGE / research analyst / LEAD MANAGER / ANALYST / internal candidate / Speculative Analyst / /

Product

metronidazole / SYMPTOMATIC RELIEF IS / VivaGel Coated Condom / Taxotere / Prescription Drug / CY2H15 / VivaGel / If / CY1H15 / FY15 / /

Technology

drug delivery / dendrimer technology / drug-delivery / Biotechnology / trial protocol / platform technology / /

URL

www.bellpotter.com.au / /

SocialTag